Usana Health Sciences
USNA
139 hedge funds and large institutions have $180M invested in Usana Health Sciences in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 40 increasing their positions, 51 reducing their positions, and 10 closing their positions.
190% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 10
15% more funds holding
Funds holding: 121 → 139 (+18)
1.67% less ownership
Funds ownership: 57.35% → 55.68% (-1.7%)
13% less capital invested
Capital invested by funds: $206M → $180M (-$26.3M)
22% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 51
85% less call options, than puts
Call options by funds: $30K | Put options by funds: $206K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$4.77M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.47M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.01M |
| 4 |
BlackRock
New York
|
+$1.56M |
| 5 |
Lazard Asset Management
New York
|
+$1.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.82M |
| 2 |
Morgan Stanley
New York
|
-$2.88M |
| 3 |
Renaissance Technologies
New York
|
-$2.57M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.27M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.19M |
USNA Hedge Fund Activity: Q1 2026 in Review
139 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q1 2026, worth a combined $180M — down 13% from $206M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new USNA positions and 10 closed out — a net gain of 19 holders — while 40 added to existing stakes and 51 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $4.77M. The largest seller was Millennium Management, cutting an estimated $3.82M.
- 139 institutional investors held Usana Health Sciences (USNA) as of Q1 2026, up from 121 in Q4 2025.
- Funds reported $180M of Usana Health Sciences stock for Q1 2026, down 13% quarter-over-quarter.
- 29 funds opened new Usana Health Sciences positions in Q1 2026 and 10 closed out, a net change of +19 holders.
- The largest Usana Health Sciences buyer in Q1 2026 was AQR Capital Management, an estimated $4.77M added.
- The largest Usana Health Sciences seller in Q1 2026 was Millennium Management, an estimated $3.82M sold.
Based on aggregated 13F filings for Q1 2026.